Hemab Therapeutics Holdings, Inc.

US$49.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:COAGHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$2.290B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$52
5.51%
(66.42%)
Hold 1|0|11|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.13
1.08
1.17
1.16
11.79%
12.09%
12.86%
3.86%
Revenue$M
205.6
203.6
201.8
205.5
20.00%
12.62%
5.69%
4.42%
Peers (US$2.290B)
Cap (US$)
PE
2.280B
—
2.208B
—
Capital
TTM
5Y
10Y
Leveragex
1.160
0.164
0.147
EBIT/Intx
0.750
2.961
2.833
Own earn%
50.10
9.48
3.10
Sh yield%
54.69
39.70
37.60
Owners
Insiders/Inst%
11.49
75.12
Short interest%
1.44
SBC / revenue%
0.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
16–19
$1 testx
0.0
Incr. ROIC%
7